The AKT1 E17K mutation was found in 5 out of 61 (8.2%) breast cancers, 3 out of 51 (5.9%) colorectal cancers and 1 out of 50 (2.0%) ovarian cancers (Carpten et al, 2007). The gene discussed is AKT1; the disease is breast carcinoma.